7Jan2020 We’ve Been Neglecting Common Diseases. We Need to Reverse this Trend /Alex Harding/1/All, Politics, Venture Capital07 Jan 2020 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.